Analysis of T-cell receptor beta chain variable gene segment usage in healthy adult responders and nonresponders to recombinant hepatitis B vaccine

Scandinavian Journal of Immunology

Volumn 57, Issue 5, 2003, Pages 423-431

  Soroosh, P ^a   Shokri, F ^a,b   Azizi, M ^c   Jeddi Tehrani, M ^d,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b National Cell Bank of Iran   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d Avesina Research Center   (Iran)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HEBERBIOVAC; HEPATITIS B ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DRUG RESPONSE; FEMALE; GENE EXPRESSION; GENE PROBE; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE CLONE; MALE; MONONUCLEAR CELL; MULTIGENE FAMILY; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VACCINATION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GENES, IMMUNOGLOBULIN; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MALE; MODELS, IMMUNOLOGICAL; POLYMORPHISM, GENETIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; VACCINES, SYNTHETIC;

EID: 0038292048     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01256.x     Document Type: Article

References (42)

1. Jenson H. Non-responders to Hepatitis B vaccine. Postgrad Med 2000;107:97.
2. Zuckerman J, Zuckerrnan A, Du Symington IW, Williams A, Dickson B et al. Evaluation of new hepatitis B triple-antigen vaccine in inadequated responders to current vaccine. Hepatology 2001;34:798-802.
3. Shokri F, Jafarzadeh A. High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates. Vaccine 2001;14:4544-8.
4. Shokri F, Amani A. High rate seroconversion following administration of a single supplementary dose of recombinant hepatitis B vaccine in Iranian healthy non-responder neonates. Med Microbiol Immunol 1997;185:231-5.
5. McDermott A, Cohen S, Zuckerman J, Madrigal J. Human leuckocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine. Vaccine 1999;17:330-9.
6. Rajadhyaksha M, Thanavala Y. Differenrial antigen presenration of hepatiris B surface antigen on cell membrane of responder and non-responder mice. Tissue Antigens 1995;45:88-96.
7. Larsen C, Xu J, Lee S et al. Complex cytokine reponses ro hepatiris B surface antigen and retanus toxin in responders, nonresponders and subjecrs naive ro hepatitis B surface antigen. Vaccine 2000;18:3021-30.
8. Kardar G, Jeddi-Tehrani M, Shokri F. Diminished Th1 and Th2 cytokines production in healthy adult non-responders to recombinanr hepatiris B vaccine. Scand J Immunol 2002;55:311-4.
9. Milich D, Jonse S, Huges J, Price J, Raney A, McLachlan A. Is a function of the secreted HBe anrigen to induce immunological tolerance in utero? Proc Narl Acad Sci USA 1990;87:6599-603.
10. Shokrgozar MA, Shokri F. Enumeration of hepatitis B surface antigen-specific B lymphocytes in responder and non-responder normal individuals with recombinant hepatitis B surface antigen. Immunology 2001;104:75-9.
11. Chedid M, Deulofeut H, Yunis D et al. Defect in Th1-like cells of nonresponders to hepariris B vaccine. Hum Immunol 1997;58:42-51.
12. Meuer S, Fitzgerald K, Hussey R, Hodgdon J, Schlossman S, Reinherz E. Clonotypic structures involved in anrigen-specific human T-cell function. J Exp Med 1983;157:705-19.
13. Davis M, Bjorkman P. T-cell antigen recepror genes and T-cell recognition. Nature 1988;334:395.
14. Garcia K, Degano M, Stanfield R et al. An αβ T-cell recepror srrucrure at 2.5 A and its orientarion in TCR-MHC complex. Science 1996;274:209.
15. Garboczi D, Ghosh P, Utz U, Fan Q, Biddison W, Wiley D. Srrucrure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996;384:134-41.
16. Groski J, Yassai M, Zhu X, Kisella B, Keever C, Flomenberg N. Circulating T-cell reperroire complexity in normal individuals and bone marrow recipients analysed by CDR3 size specrratyping. J Immunol 1994;152:5109.
17. Pannerier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourllsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 1993;90:4319.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156.
19. Doherty J, Roifman M, Sueihua P et al. Expression of the human T-cell recetor Vβ repertoire. Mol Immunol 1991;28:607.
20. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd edn.: Cold Spring Harbor, 1989.
21. Grunewald J, Jeddi-Tehrani M, Andersson R, Simonian HD, Wigzell H. A persistent monoclonal T-cell expansion in the peripheral blood of a normal adult male: a new dinical entity? Clin Exp Immunol 1992;89:279.
22. Cochet M, Pannetier C, Regnault A, Darche S, Lecrec C, Kourilsky P. Molecular detection and in vivo analysis of the specific T-cell response to a protein antigen. Eur J Immunol 1992;22:2639.
23. + T-cell expansions are found preferentially in patients with low tumor burden. Eur J Immunol 1997;27:2245.
24. Germain R. The second class story. Nature 1991;353:605-6.
25. Salazar M, Deulofeut R, Garja C et al. Normal HBsAg presentation and T-cell defect in the immune response of nonresponders. Immunogenetics 1995;41:366.
26. Desombere I, Hauser P, Rossau R, Paradijs J, Leroux-Roels G. Nonresponder to hepatitis B vaccine can presenr envelope partides to T lymphocytes. J Immunol 1995;154:520.
27. Borght AV, Geusens P, Vandevyver C, Raus J, Srinissen P. Skewed T-cell receptor variable gene usage in the synovium of early and chronic rheumaroid arthritis patients and persistence of clonally expanded T-cells in a chronic parienr. Rheumarology 2000;39:1189-201.
28. Pira GL, Bottone L, Fenoglio D et al. Analysis of the antigen specific T-cell repertoire in HIV infection. Immunol Lert 2001;79:85-91.
29. Yuh K, Sugyo S, Nakamura K et al. Analysis of human T-cell antigen receptor variable bera gene usage following vaccination with recombinant HBsAg. Dig Dis Sci 1998;43:880-6.
30. + cells in virro determined by TcR BV CDR3 length and nucleotide sequence. Genes Immunol 2001;2:11-9.
31. + T cells in hepatitis B vaccine non-responders. J Gastroenrerol Hepatol 2001;16:898-903.
32. Desombere I, Gijbels Y, Verwulgen A, Leroux-Roels G. Charcrerization of T-cell recognition of heparitis B surface antigen (HBsAg) by good and poor responders to heparitis B vaccine. J Exp Immunol 2000;122:390-9.
33. Kayser C, Wasse I, Weyand C, Goronzy J. T-cell receptor germline gene segments and HLA haplotypes control the length of the CDR3 of human T-cell receptor β chains. Cell Immunol 1996;168:235-42.
34. Barbey C, Watts C, Corradin G. Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display deferential degradarion activity. Eur J Immunol 1995;25:30-6.
35. Akolkar P, Gulwani B, Pergolizzi K, Bigler I, Silver J. Influence of HLA genes on T-cell recepror V segmenr frequencies and expression levels in peripheral blood lymphocytes. J Immunol 1993;150:2761-73.
36. Jacobs MJ, Hoek Aevd, Putre LBvd, Berg WBvd. Anergy of antigen specific T lymphocytes is a porent mechanisms of inrravenously induced tolerance. Immunology 1994;82:294.
37. + suppressor T-cells. Tissue Antigens 1990;36:69.
38. Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F. Selective killing of hepatitis B envelope antigen-specific B-cell by class I-restricted exogenous antigen-specific T-lymphocytes. Nature 1990;345:258.
39. Egea E, Iglesias A, Salazar M et al. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Immunol 1991;173:531-8.
40. Schirmbeck R, Melber K, Mertens T, Reimann J. Antibody and cytotoxic T-cell response to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J Virol 1994;68:1418-25.
41. + suppressor T-cells. Immunol Rev 2001;182:58-67.
42. Ng W, Duggan P, Ponchel F et al. Human CD4(+) CD25(+) cells: a naturally occurring population of regulatory T-cells. Blood 2001;98:2736-44.